Concepts (162)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Enterobacteriaceae | 2 | 2017 | 395 | 0.26 | Why? |
| Enterobacteriaceae Infections | 2 | 2021 | 529 | 0.25 | Why? |
| Baths | 2 | 2020 | 62 | 0.25 | Why? |
| Vancomycin-Resistant Enterococci | 3 | 2018 | 104 | 0.24 | Why? |
| Carbapenem-Resistant Enterobacteriaceae | 2 | 2021 | 214 | 0.22 | Why? |
| Clostridium | 1 | 2018 | 33 | 0.19 | Why? |
| Intestinal Diseases, Parasitic | 1 | 2018 | 34 | 0.18 | Why? |
| Bacterial Load | 1 | 2018 | 179 | 0.18 | Why? |
| Blood Culture | 1 | 2020 | 308 | 0.17 | Why? |
| Skin Care | 1 | 2017 | 49 | 0.17 | Why? |
| Epidermolysis Bullosa | 1 | 2017 | 60 | 0.17 | Why? |
| Streptococcus | 1 | 2017 | 76 | 0.17 | Why? |
| Feces | 4 | 2018 | 4235 | 0.17 | Why? |
| Roseolovirus Infections | 1 | 2018 | 131 | 0.17 | Why? |
| Penicillanic Acid | 1 | 2017 | 58 | 0.17 | Why? |
| Wound Infection | 1 | 2017 | 66 | 0.17 | Why? |
| Methicillin-Resistant Staphylococcus aureus | 3 | 2018 | 711 | 0.16 | Why? |
| Molecular Diagnostic Techniques | 4 | 2021 | 4239 | 0.16 | Why? |
| Enteritis | 1 | 2018 | 147 | 0.16 | Why? |
| Meningitis | 1 | 2018 | 163 | 0.16 | Why? |
| Herpesvirus 6, Human | 1 | 2018 | 162 | 0.16 | Why? |
| Chlorhexidine | 1 | 2018 | 176 | 0.15 | Why? |
| Anti-Bacterial Agents | 7 | 2021 | 10083 | 0.15 | Why? |
| Neck | 1 | 2018 | 307 | 0.15 | Why? |
| Cephalosporins | 1 | 2017 | 250 | 0.15 | Why? |
| beta-Lactamases | 2 | 2021 | 759 | 0.14 | Why? |
| Carbapenems | 1 | 2017 | 343 | 0.14 | Why? |
| Bacteremia | 3 | 2020 | 1372 | 0.14 | Why? |
| Vancomycin | 1 | 2017 | 328 | 0.13 | Why? |
| New York City | 7 | 2021 | 7432 | 0.13 | Why? |
| Rectum | 1 | 2017 | 495 | 0.13 | Why? |
| Staphylococcus aureus | 2 | 2017 | 844 | 0.13 | Why? |
| Streptococcal Infections | 1 | 2017 | 255 | 0.13 | Why? |
| Reagent Kits, Diagnostic | 2 | 2021 | 2149 | 0.13 | Why? |
| Infectious Disease Transmission, Vertical | 2 | 2021 | 5164 | 0.13 | Why? |
| Viral Load | 4 | 2021 | 15850 | 0.12 | Why? |
| Sexually Transmitted Diseases | 1 | 2021 | 694 | 0.12 | Why? |
| Surgical Wound Infection | 1 | 2018 | 501 | 0.12 | Why? |
| Bacterial Proteins | 2 | 2021 | 1318 | 0.12 | Why? |
| Diagnostic Tests, Routine | 2 | 2021 | 2643 | 0.12 | Why? |
| Intestines | 1 | 2018 | 817 | 0.11 | Why? |
| Intensive Care Units, Neonatal | 1 | 2017 | 749 | 0.11 | Why? |
| Celiac Disease | 1 | 2018 | 471 | 0.11 | Why? |
| Anti-Infective Agents, Local | 1 | 2018 | 520 | 0.11 | Why? |
| Drug Resistance, Bacterial | 2 | 2017 | 1414 | 0.11 | Why? |
| Staphylococcal Infections | 2 | 2017 | 1099 | 0.11 | Why? |
| Point-of-Care Testing | 2 | 2021 | 2782 | 0.10 | Why? |
| Drug Resistance, Multiple, Bacterial | 1 | 2018 | 1115 | 0.10 | Why? |
| Gastrointestinal Tract | 1 | 2018 | 1113 | 0.10 | Why? |
| Pregnancy Outcome | 2 | 2021 | 3803 | 0.10 | Why? |
| Multiplex Polymerase Chain Reaction | 1 | 2018 | 1439 | 0.10 | Why? |
| Nucleic Acid Amplification Techniques | 2 | 2021 | 3388 | 0.10 | Why? |
| Breast Feeding | 1 | 2020 | 1585 | 0.10 | Why? |
| Pregnancy Complications, Infectious | 3 | 2021 | 11559 | 0.10 | Why? |
| New York | 3 | 2020 | 2488 | 0.09 | Why? |
| Gastrointestinal Microbiome | 2 | 2018 | 1961 | 0.09 | Why? |
| Preoperative Care | 1 | 2018 | 1515 | 0.09 | Why? |
| Bacteria | 1 | 2018 | 1897 | 0.08 | Why? |
| Patient Isolation | 1 | 2020 | 3182 | 0.08 | Why? |
| Carrier State | 1 | 2018 | 2100 | 0.08 | Why? |
| Infant, Newborn | 7 | 2021 | 23105 | 0.08 | Why? |
| Clinical Laboratory Techniques | 4 | 2021 | 23402 | 0.08 | Why? |
| Organ Transplantation | 1 | 2021 | 2616 | 0.08 | Why? |
| Diarrhea | 1 | 2018 | 2743 | 0.07 | Why? |
| Skin | 1 | 2018 | 2096 | 0.07 | Why? |
| Saliva | 1 | 2021 | 4679 | 0.07 | Why? |
| Bacterial Infections | 1 | 2018 | 2229 | 0.07 | Why? |
| Genetic Variation | 1 | 2018 | 3919 | 0.07 | Why? |
| Gastrointestinal Diseases | 1 | 2018 | 2580 | 0.06 | Why? |
| Limit of Detection | 2 | 2021 | 2698 | 0.06 | Why? |
| Postoperative Complications | 1 | 2021 | 5861 | 0.06 | Why? |
| Female | 22 | 2021 | 380317 | 0.06 | Why? |
| Liver Transplantation | 1 | 2018 | 2864 | 0.06 | Why? |
| Male | 21 | 2021 | 367725 | 0.06 | Why? |
| Neoplasms | 2 | 2020 | 17251 | 0.06 | Why? |
| Cross Infection | 3 | 2018 | 8675 | 0.06 | Why? |
| Retrospective Studies | 10 | 2021 | 105322 | 0.05 | Why? |
| Aged | 15 | 2021 | 215776 | 0.05 | Why? |
| Rooming-in Care | 1 | 2020 | 53 | 0.05 | Why? |
| Virus Diseases | 1 | 2018 | 3779 | 0.05 | Why? |
| Inflammatory Bowel Diseases | 1 | 2018 | 3209 | 0.05 | Why? |
| Coinfection | 1 | 2020 | 6820 | 0.05 | Why? |
| Middle Aged | 15 | 2021 | 270681 | 0.05 | Why? |
| Infant | 5 | 2020 | 30274 | 0.05 | Why? |
| Prospective Studies | 6 | 2020 | 43301 | 0.05 | Why? |
| Diagnostic Techniques and Procedures | 1 | 2021 | 265 | 0.05 | Why? |
| Microbial Sensitivity Tests | 2 | 2017 | 2886 | 0.05 | Why? |
| Young Adult | 8 | 2021 | 93724 | 0.05 | Why? |
| Humans | 27 | 2021 | 930598 | 0.04 | Why? |
| Chlamydia Infections | 1 | 2021 | 248 | 0.04 | Why? |
| Piperacillin | 1 | 2017 | 63 | 0.04 | Why? |
| Serratia marcescens | 1 | 2017 | 38 | 0.04 | Why? |
| Vancomycin Resistance | 1 | 2017 | 55 | 0.04 | Why? |
| Multiple Chronic Conditions | 1 | 2018 | 115 | 0.04 | Why? |
| Reverse Transcription | 1 | 2021 | 673 | 0.04 | Why? |
| Enterococcus | 1 | 2017 | 73 | 0.04 | Why? |
| Administration, Cutaneous | 1 | 2018 | 229 | 0.04 | Why? |
| Respiratory Tract Infections | 1 | 2018 | 6817 | 0.04 | Why? |
| Coronavirus Infections | 6 | 2020 | 253789 | 0.04 | Why? |
| Betacoronavirus | 5 | 2020 | 204454 | 0.04 | Why? |
| Postnatal Care | 1 | 2020 | 346 | 0.04 | Why? |
| Gonorrhea | 1 | 2021 | 315 | 0.04 | Why? |
| Aged, 80 and over | 7 | 2020 | 88759 | 0.04 | Why? |
| RNA, Viral | 2 | 2021 | 32276 | 0.04 | Why? |
| Age of Onset | 1 | 2018 | 557 | 0.04 | Why? |
| Adolescent | 7 | 2020 | 86841 | 0.04 | Why? |
| Phenotype | 2 | 2017 | 4037 | 0.04 | Why? |
| Principal Component Analysis | 1 | 2018 | 689 | 0.04 | Why? |
| Sensitivity and Specificity | 3 | 2021 | 22971 | 0.04 | Why? |
| Case-Control Studies | 3 | 2020 | 17671 | 0.04 | Why? |
| Seasons | 2 | 2018 | 4071 | 0.04 | Why? |
| Genotype | 2 | 2017 | 4697 | 0.04 | Why? |
| RNA, Ribosomal, 16S | 1 | 2018 | 793 | 0.04 | Why? |
| Pneumonia, Viral | 5 | 2020 | 243684 | 0.04 | Why? |
| Organizational Policy | 1 | 2020 | 694 | 0.04 | Why? |
| Child, Preschool | 4 | 2020 | 36283 | 0.04 | Why? |
| Chi-Square Distribution | 1 | 2018 | 961 | 0.04 | Why? |
| HIV Infections | 1 | 2021 | 11620 | 0.04 | Why? |
| Vagina | 1 | 2017 | 327 | 0.03 | Why? |
| Hospitalization | 3 | 2020 | 54280 | 0.03 | Why? |
| Encephalitis, Viral | 1 | 2018 | 355 | 0.03 | Why? |
| Predictive Value of Tests | 2 | 2020 | 9537 | 0.03 | Why? |
| Pregnancy | 3 | 2021 | 23879 | 0.03 | Why? |
| Logistic Models | 2 | 2018 | 9089 | 0.03 | Why? |
| Adult | 9 | 2021 | 244371 | 0.03 | Why? |
| Follow-Up Studies | 2 | 2021 | 17020 | 0.03 | Why? |
| Healthy Volunteers | 1 | 2018 | 1444 | 0.03 | Why? |
| Combined Modality Therapy | 1 | 2020 | 3395 | 0.03 | Why? |
| Sentinel Surveillance | 1 | 2018 | 1093 | 0.03 | Why? |
| Temperature | 1 | 2021 | 2305 | 0.03 | Why? |
| Hospitals | 2 | 2021 | 11793 | 0.03 | Why? |
| Child | 4 | 2020 | 70012 | 0.02 | Why? |
| Whole Genome Sequencing | 1 | 2018 | 3239 | 0.02 | Why? |
| Multivariate Analysis | 1 | 2018 | 5440 | 0.02 | Why? |
| Prevalence | 2 | 2020 | 25773 | 0.02 | Why? |
| Prognosis | 2 | 2020 | 32490 | 0.02 | Why? |
| Genomics | 1 | 2018 | 3118 | 0.02 | Why? |
| Odds Ratio | 1 | 2018 | 5861 | 0.02 | Why? |
| Survival Rate | 1 | 2020 | 9206 | 0.02 | Why? |
| Community-Acquired Infections | 1 | 2018 | 2328 | 0.02 | Why? |
| Cohort Studies | 2 | 2021 | 36005 | 0.02 | Why? |
| Comorbidity | 2 | 2021 | 34796 | 0.02 | Why? |
| Time Factors | 2 | 2018 | 31397 | 0.02 | Why? |
| Risk Factors | 3 | 2018 | 71621 | 0.02 | Why? |
| Critical Illness | 2 | 2018 | 17281 | 0.02 | Why? |
| Specimen Handling | 1 | 2021 | 6190 | 0.02 | Why? |
| Polymerase Chain Reaction | 1 | 2018 | 6740 | 0.02 | Why? |
| Caregivers | 1 | 2017 | 3112 | 0.02 | Why? |
| Pandemics | 5 | 2020 | 389249 | 0.01 | Why? |
| Asymptomatic Infections | 1 | 2021 | 7218 | 0.01 | Why? |
| Phylogeny | 1 | 2021 | 13341 | 0.01 | Why? |
| Transplant Recipients | 1 | 2018 | 4982 | 0.01 | Why? |
| Immunocompromised Host | 1 | 2018 | 5150 | 0.01 | Why? |
| Nasopharynx | 1 | 2021 | 10224 | 0.01 | Why? |
| Intensive Care Units | 2 | 2018 | 29594 | 0.01 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2018 | 13720 | 0.01 | Why? |
| Critical Care | 1 | 2018 | 14081 | 0.01 | Why? |
| Cross-Sectional Studies | 1 | 2018 | 53120 | 0.01 | Why? |
| United States | 1 | 2017 | 46150 | 0.01 | Why? |
| Severity of Illness Index | 1 | 2018 | 48226 | 0.01 | Why? |
| Coronavirus | 1 | 2018 | 18339 | 0.01 | Why? |
| Antiviral Agents | 1 | 2021 | 41703 | 0.01 | Why? |